Investment Summary

Vitruvian Partners Invests In MaxCyte

On November 15, 2021, private equity firm Vitruvian Partners invested in life science company MaxCyte

Investment Highlights
  • This is Vitruvian Partners’ 3rd transaction in the Life Science sector.
  • This is Vitruvian Partners’ 7th transaction in the United States.
  • This is Vitruvian Partners’ 1st transaction in Maryland.

Investment Summary

Date 2021-11-15
Target MaxCyte
Sector Life Science
Investor(s) Vitruvian Partners
Deal Type Stake Purchase

Target

MaxCyte

Rockville, Maryland, United States
MaxCyte discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. MaxCyte was founded in 1998 and is headquartered in Rockville, Maryland.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Vitruvian Partners

London, United Kingdom

Category Private Equity Firm
Founded 2006
PE ASSETS 20.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Vitruvian Partners is an independent private equity firm that specializes in middle-market buyouts, growth buyouts and growth capital investments in the UK and elsewhere in Northern Europe. Vitruvian looks for companies that are 'operating in dynamic situations, where there is an opportunity to build strategic value'. The Group's target investment size is €40 to €600 million in transactions valued between €75m to €4bn. Sectors of interest include business services, consumer services, financial services, life science, healthcare services, media, technology, communications, and internet software. Vitruvian Partners was formed in 2006 and is based in London.


DEAL STATS #
Overall 52 of 69
Sector: Life Science M&A 3 of 3
Type: Stake Purchase M&A Deals 8 of 11
State: Maryland M&A 1 of 1
Country: United States M&A 7 of 12
Year: 2021 M&A 9 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-21 Dental Monitoring

Paris, France

Dental Monitoring is a provider of healthcare development monitoring solution in orthodontic care. Dental Monitoring was founded in 2014 and is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-28 ClimatePartner

Munich, Germany

ClimatePartner provides a turnkey solution for corporates to estimate, reduce and offset their carbon footprint – a crucial step in the journey to NetZero. With its solutions, it helps companies to calculate and reduce their carbon emissions and offset residual emissions through a broad portfolio of strictly certified carbon offset projects. ClimatePartner was founded in 2006 and is based in Munich, Germany.

Buy -